Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD1B | P29016 | T-cell surface glycoprotein CD1b (CD antigen CD1b) | CD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.53 | |||
| CD1C | P29017 | T-cell surface glycoprotein CD1c (CD antigen CD1c) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| CD2 | P06729 | T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | LymphomaPsoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CD226 | Q15762 | CD226 antigen (DNAX accessory molecule 1) (DNAM-1) (CD antigen CD226) | CD markersHuman disease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.53 | |||
| CD302 | Q8IX05 | CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.53 | ||||
| CD37 | P11049 | Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 4 | Diffuse large B-cell lymphomaLeukaemiaMalignant haematopoietic neoplasm | Clinical-translation mediation | 1 | 0.53 | ||
| CD40L | P29965 | CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)] | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | B-cell lymphomaDiabetes mellitusDiffuse large B-cell lymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CD69 | Q07108 | Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD antigen CD69) | CD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | |||
| CD79B | P40259 | B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b) | Cancer-related genesCD markersDisease related genes | 1 | Autoimmune diseaseDiffuse large B-cell lymphomaFollicular lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Diabetes mellitusLung cancerLymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 |